BioCorRx Inc.
BICX
$0.41
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 4,355.00% | 3,647.22% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 4,355.00% | 3,647.22% | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -100.00% |
| Gross Profit | -- | -- | 4,355.00% | 6,645.00% | -100.00% |
| SG&A Expenses | -35.72% | -3.98% | 47.33% | 18.13% | 20.99% |
| Depreciation & Amortization | -1,060.00% | 974.63% | 974.63% | 270.15% | 94.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -65.94% | 55.50% | 15.93% | 10.34% | 33.62% |
| Operating Income | 52.50% | -17.23% | -3.25% | 3.18% | -36.71% |
| Income Before Tax | 61.62% | 46.56% | -11.61% | 31.17% | -26.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 61.62% | 46.56% | -11.61% | 31.17% | -26.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,525.08% | -4,433.59% | 761.68% | 1,385.71% | 12,500.00% |
| Net Income | 147.45% | -28.94% | -1.32% | 31.97% | -20.25% |
| EBIT | 52.50% | -17.23% | -3.25% | 3.18% | -36.71% |
| EBITDA | 52.94% | -13.35% | 1.52% | 5.08% | -36.24% |
| EPS Basic | 125.98% | 22.58% | 43.67% | 60.55% | 18.43% |
| Normalized Basic EPS | 158.80% | -15.01% | 49.75% | 66.67% | 23.93% |
| EPS Diluted | 125.98% | 22.58% | 43.67% | 60.55% | 18.43% |
| Normalized Diluted EPS | 158.80% | -15.01% | 49.75% | 66.67% | 23.93% |
| Average Basic Shares Outstanding | 82.72% | 66.50% | 79.84% | 72.36% | 47.48% |
| Average Diluted Shares Outstanding | 82.72% | 66.50% | 79.84% | 72.36% | 47.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |